Bilic, Sanela,Camacho Gomez, Juan Alberto,Cameron, John Scott,Castro-Palomino Laria, Julio Cesar,Howard, Danny Roland
申请号：
HRP20192192
公开号：
HRP20192192T1
申请日:
2019.12.04
申请国别(地区):
HR
年份:
2020
代理人:
摘要：
To provide new therapies for the treatment of cancer with a low survival rate, represented by non-small cell lung cancer (NSCLC).SOLUTION: A combination product comprises a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt or co-crystal thereof, and one or more immunotherapeutic agents selected from the group consisting of an anti-CTLA4 antibody, an anti-PD-1 antibody and an anti-PD-L1 antibody.SELECTED DRAWING: None
